Screening for impaired glucose tolerance: Results from a population- based study in 21,057 individuals

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 1988-1992

  Lindahl, Bernt ^a   Weinehall, Lars ^a   Asplund, Kjell ^a   Hallmans, Göran ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; SCREENING TEST; SWEDEN;

EID: 0033361044     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.1988     Document Type: Article

References (29)

1. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
2. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
3. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
4. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall Study. Lancet 1:1373-1376, 1980
5. Jarrett RJ, McCartney P, Keen H: The Bedford Survey ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
6. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
7. DeFronzo RA, Ferrannini MD: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
8. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM. Diabetes Care 15:318-368, 1992
9. Modan M, Halkin H, Shlomo A, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 75:809-817, 1985
10. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widén E, Schalin C, Groop L: Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
11. Davies MJ, Rayman G, Grenfell A, Gray IP, Day JL, Hales CN: Loss of first phase insulin response to intravenous glucose in subjects with persistent impaired glucose tolerance. Diabet Med 11:432-436, 1994
12. Beck-Nielsen H, Groop LC: Metabolic and genetic characterization of prediabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721, 1994
13. Tuomilehto J, Knowler WC, Zimmet P: Primary prevention of non-insulin-dependent diabetes mellitus. Diabet Metab Rev 8:339-353, 1992
14. Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM: Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? BMJ 301:397-402, 1990
15. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ: Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia 39:113-118, 1996
16. World Health Organization: Prevention of Diabetes Mellitus. Geneva, World Health Org., 1994 (Tech. Rep. Ser., no 844)
17. Knowler WC, Narayan KMV, Hanson RL, Nelson RG, Bennett PH, Tuomilehto J, Scherstén B, Pettitt DJ: Perspectives in diabetes: preventing non-insulin-dependent diabetes. Diabetes 44:483-488, 1995
18. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. Alberti KGMM, Zimmet P, for the WHO Consultation Group: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Diabet Med 15:539-553, 1998
20. Weinehall E, Hallgren C-G, Westman G, Janlert U, Wall S: Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care 16:171-176, 1998
21. von Schenk H, Treichl L, Tilling B, Olsson AG: Laboratory and field evaluation of three desk top instruments for blood cholesterol and triglyceride assay. Clin Chem 33:1230-1232, 1987
22. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
23. Harris MI: Impaired glucose tolerance in the U.S. population. Diabetes Care 12:464-474, 1989
24. Forrest RD, Jackson CA, Yudkin JS: The abbreviated glucose tolerance test in screening for diabetes: the Islington Diabetes Survey. Diabet Med 5:557-561, 1988
25. Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years: the WHO MONICA Project. World Health Stat Q 41: 115-140, 1988
26. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH: A two-step model for the development of non-insulin-dependent diabetes. Am J Med 90:229-235, 1991
27. Edelstein SE, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46:701-710, 1997
28. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
29. Mudaliar SR, Henry RR: Strategies for preventing type II diabetes: what can be done to stem the epidemic? Postgrad Med 101: 181-189, 1997